Radiolytic Nanoparticle Delivery of Radiation Sensitizers for BRCA-Proficient Triple Negative Breast Cancer

被引：0
|
作者：
DuRoss, A. N. [1 ]
Rosch, J. [1 ]
Brown, A. [1 ]
Sahay, G. [1 ]
Jaboin, J. J. [2 ]
Thomas, C. R., Jr. [2 ,3 ]
Sun, C. [1 ,2 ]
机构：
[1] Oregon State Univ, Corvallis, OR 97331 USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.2012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3396
引用
收藏
页码：E586 / E587
页数：2
相关论文
共 50 条
  • [21] BRCA1 methylation in triple-negative breast cancer
    Kawachi, A.
    Okochi-Takada, E.
    Shimoi, T.
    Shimomura, A.
    Kodaira, M.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Ushijima, T.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2015, 26 : 28 - 29
  • [22] Triple Negative Breast Cancer and BRCA Status: Implications for Genetic Counseling
    Hague, R.
    Alvarado, M.
    Ahmed, S. A.
    Shi, J. M.
    Chung, J. W. L.
    Avila, C. C.
    Zheng, C. X.
    Tiller, G. E.
    CANCER RESEARCH, 2012, 72
  • [23] BRCA2 Mutations and Triple-Negative Breast Cancer
    Meyer, Peter
    Landgraf, Katharina
    Hoegel, Bernhard
    Eiermann, Wolfgang
    Ataseven, Beyhan
    PLOS ONE, 2012, 7 (05):
  • [24] BRCA1 testing for triple-negative breast cancer
    Bennet, Neil
    LANCET ONCOLOGY, 2012, 13 (04): : E143 - E143
  • [25] Triple-negative breast cancer and BRCA mutation: looking at the future
    Ballatore, Z.
    Pistelli, M.
    Bracci, R.
    Bianchi, F.
    Maccaroni, E.
    Belvederesi, L.
    Brugiati, C.
    Pagliaretta, S.
    De Lisa, M.
    Della Mora, A.
    Cantini, L.
    Bastianelli, L.
    Pagliacci, A.
    Battelli, N.
    Berardi, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [26] Biological features of triple negative BRCA-related breast cancer
    Botiralieva, G.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S14 - S14
  • [27] Prognostic value of BRCA mutations in triple-negative breast cancer
    Guerrero-Setas, D.
    Freire, J.
    Garcia-Berbel, P.
    Ruiz De Azua, Y.
    De la Cruz, S.
    Armendariz, P.
    Mercado, M. D. R.
    Aguiar, B.
    Arriola, M.
    Gomez-Roman, J.
    Cordoba, A.
    VIRCHOWS ARCHIV, 2020, 477 : S143 - S144
  • [28] Triple negative breast cancer: new therapeutic approaches and BRCA status
    Eskiler, Gamze Guney
    Cecener, Gulsah
    Egeli, Unal
    Tunca, Berrin
    APMIS, 2018, 126 (05) : 371 - 379
  • [29] Imaging Features of Triple Negative Breast Cancer and the Effect of BRCA Mutations
    Karbasian, Niloofar
    Sohrabi, Sahand
    Omofoye, Toma S.
    Le-Petross, Huong
    Arun, Banu K.
    Albarracin, Constance T.
    Hess, Kenneth R.
    Gutierrez-Barrera, Angelica M.
    Whitman, Gary J.
    CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY, 2021, 50 (03) : 303 - 307
  • [30] Sequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticle
    Zhou, Zilan
    Kennell, Carly
    Jafari, Mina
    Lee, Joo-Youp
    Ruiz-Torres, Sasha J.
    Waltz, Susan E.
    Lee, Jing-Huei
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 530 (1-2) : 300 - 307
12345